• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微流控制备及 iRGD 功能化固体脂质纳米粒的体外评价用于紫杉醇靶向递送至肿瘤细胞。

Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells.

机构信息

Department of Pharmacy - Pharmaceutical Sciences, University of Bari "Aldo Moro", Orabona St. 4, 70125 Bari, Italy; Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014 Helsinki, Finland.

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014 Helsinki, Finland.

出版信息

Int J Pharm. 2021 Dec 15;610:121246. doi: 10.1016/j.ijpharm.2021.121246. Epub 2021 Oct 28.

DOI:10.1016/j.ijpharm.2021.121246
PMID:34737115
Abstract

Solid lipid nanoparticles (SLNs) can combine the advantages of different colloidal carriers and prevent some of their disadvantages. The production of nanoparticles by means of microfluidics represents a successful platform for industrial scale-up of nanoparticle manufacture in a reproducible way. The realisation of a microfluidic technique to obtain SLNs in a continuous and reproducible manner encouraged us to create surface functionalised SLNs for targeted drug release using the same procedure. A tumor homing peptide, iRGD, owning a cryptic C-end Rule (CendR) motif is responsible for neuropilin-1 (NRP-1) binding and for triggering extravasation and tumor penetration of the peptide. In this study, the Paclitaxel loaded-SLNs produced by microfluidics were functionalized with the iRGD peptide. The SLNs proved to be stable in aqueous medium andwere characterized by a Z-average under 150 nm, a polydispersity index below 0.2, a zeta-potential between -20 and -35 mV and a drug encapsulation efficiency around 40%. Moreover, in vitro cytotoxic effects and cellular uptake have been assessed using 2D and 3D tumour models of U87 glioblastoma cell lines. Overall, these results demonstrate that the surface functionalization of SLNs with iRGD allow better cellular uptake and cytotoxicity ability.

摘要

固体脂质纳米粒(SLNs)可以结合不同胶体载体的优点,并避免它们的一些缺点。通过微流控技术生产纳米粒是一种成功的平台,可以以可重复的方式将纳米粒制造工业规模扩大。我们利用微流控技术连续、可重复地制备固体脂质纳米粒,这一技术的实现激励我们使用相同的方法来制备表面功能化的固体脂质纳米粒,以实现靶向药物释放。iRGD 是一种具有隐蔽 C 端规则(CendR)基序的肿瘤归巢肽,负责与神经纤毛蛋白-1(NRP-1)结合,并触发肽的血管外渗和肿瘤穿透。在本研究中,通过微流控技术制备的载紫杉醇固体脂质纳米粒用 iRGD 肽进行了功能化。SLNs 在水介质中稳定,Z 均粒径小于 150nm,多分散指数低于 0.2,zeta 电位在-20 至-35mV 之间,药物包封效率约为 40%。此外,还使用 U87 神经胶质瘤细胞系的 2D 和 3D 肿瘤模型评估了体外细胞毒性作用和细胞摄取。总的来说,这些结果表明,用 iRGD 对 SLNs 进行表面功能化可以提高细胞摄取和细胞毒性能力。

相似文献

1
Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells.微流控制备及 iRGD 功能化固体脂质纳米粒的体外评价用于紫杉醇靶向递送至肿瘤细胞。
Int J Pharm. 2021 Dec 15;610:121246. doi: 10.1016/j.ijpharm.2021.121246. Epub 2021 Oct 28.
2
Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique.微流控技术制备棕榈酸十六酯基聚乙二醇化固体脂质纳米粒
Acta Biomater. 2021 Feb;121:566-578. doi: 10.1016/j.actbio.2020.12.024. Epub 2020 Dec 14.
3
iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.整合素靶向肽iRGD偶联增强了聚合物囊泡介导的紫杉醇腹腔内肿瘤递送。
Biomaterials. 2016 Oct;104:247-57. doi: 10.1016/j.biomaterials.2016.07.023. Epub 2016 Jul 20.
4
Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.载紫杉醇和柚皮素的固体脂质纳米粒经环肽表面修饰后,提高了在多形性胶质母细胞瘤中的肿瘤靶向能力。
Biomed Pharmacother. 2021 Jun;138:111461. doi: 10.1016/j.biopha.2021.111461. Epub 2021 Mar 9.
5
Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel.用于紫杉醇肺部靶向递送的甘露糖基化固体脂质纳米粒。
Drug Dev Ind Pharm. 2015 Apr;41(4):640-9. doi: 10.3109/03639045.2014.891130. Epub 2014 Feb 24.
6
Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles.紫杉醇负载的空间稳定固体脂质纳米粒的制备、表征及体外细胞毒性
Biomaterials. 2007 Apr;28(12):2137-46. doi: 10.1016/j.biomaterials.2007.01.014. Epub 2007 Jan 10.
7
Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel.用于提高紫杉醇口服生物利用度的基于脂质的纳米粒的开发。
AAPS PharmSciTech. 2011 Jun;12(2):712-22. doi: 10.1208/s12249-011-9636-8. Epub 2011 Jun 3.
8
Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy.载紫杉醇的脂质纳米粒微流控制剂用于化疗。
Int J Pharm. 2022 Nov 25;628:122320. doi: 10.1016/j.ijpharm.2022.122320. Epub 2022 Oct 19.
9
The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.穿膜肽 iRGD 对载紫杉醇的 MT1-AF7p 偶联纳米粒对神经胶质瘤细胞作用的影响。
Biomaterials. 2013 Jul;34(21):5138-48. doi: 10.1016/j.biomaterials.2013.03.036. Epub 2013 Apr 9.
10
Microfluidic assembly of "Turtle-Like" shaped solid lipid nanoparticles for lysozyme delivery.用于溶菌酶递送的“类龟”形固体脂质纳米颗粒的微流体制备
Int J Pharm. 2023 Jan 25;631:122479. doi: 10.1016/j.ijpharm.2022.122479. Epub 2022 Dec 9.

引用本文的文献

1
Microfluidic synthesis of stable and uniform curcumin-loaded solid lipid nanoparticles with high encapsulation efficiency.微流控合成具有高包封率的稳定且均匀的载姜黄素固体脂质纳米粒。
RSC Adv. 2025 Apr 4;15(14):10547-10556. doi: 10.1039/d4ra08284b.
2
Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells.通过微流控技术制备仿生混合脂质体:在胶质瘤细胞中的同型靶向和抗肿瘤功效研究
Int J Nanomedicine. 2024 Dec 8;19:13217-13233. doi: 10.2147/IJN.S489872. eCollection 2024.
3
Recent Advances in Nanodrug Delivery Systems Production, Efficacy, Safety, and Toxicity.
纳米药物递送系统的研究进展:生产、疗效、安全性和毒性。
Methods Mol Biol. 2025;2834:303-332. doi: 10.1007/978-1-0716-4003-6_15.
4
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma.肽搭乘用于神经胶质瘤中纳米系统的发展。
ACS Nano. 2024 Jul 2;18(26):16359-16394. doi: 10.1021/acsnano.4c01790. Epub 2024 Jun 11.
5
Breaking barriers: The potential of nanosystems in antituberculosis therapy.突破障碍:纳米系统在抗结核治疗中的潜力
Bioact Mater. 2024 May 17;39:106-134. doi: 10.1016/j.bioactmat.2024.05.013. eCollection 2024 Sep.
6
Uncovering the Emerging Prospects of Lipid-based Nanoparticulate Vehicles in Lung Cancer Management: A Recent Perspective.揭示基于脂质的纳米颗粒载体在肺癌治疗中的新兴前景:近期观点
Pharm Nanotechnol. 2025;13(1):155-170. doi: 10.2174/0122117385286781240228060152.
7
Design of charge converting lipid nanoparticles via a microfluidic coating technique.通过微流控涂层技术设计电荷转换脂质纳米粒子。
Drug Deliv Transl Res. 2024 Nov;14(11):3173-3185. doi: 10.1007/s13346-024-01538-5. Epub 2024 Feb 21.
8
Exploring the Microfluidic Production of Biomimetic Hybrid Nanoparticles and Their Pharmaceutical Applications.探索仿生杂化纳米颗粒的微流体制备及其药物应用。
Pharmaceutics. 2023 Jul 14;15(7):1953. doi: 10.3390/pharmaceutics15071953.
9
Microfluidic encapsulation of enzymes and steroids within solid lipid nanoparticles.微流控技术将酶和甾体包封于固体脂质纳米粒中。
Drug Deliv Transl Res. 2024 Jan;14(1):266-279. doi: 10.1007/s13346-023-01398-5. Epub 2023 Jul 28.
10
Use of Microfluidics to Prepare Lipid-Based Nanocarriers.利用微流控技术制备脂质基纳米载体。
Pharmaceutics. 2023 Mar 24;15(4):1053. doi: 10.3390/pharmaceutics15041053.